Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay

Neurology. 2016 Feb 2;86(5):484-6. doi: 10.1212/WNL.0000000000002330. Epub 2016 Jan 6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • JC Virus / isolation & purification*
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Leukoencephalopathy, Progressive Multifocal / immunology
  • Natalizumab / adverse effects*

Substances

  • Immunologic Factors
  • Natalizumab